Giovanna Giorgiani
Overview
Explore the profile of Giovanna Giorgiani including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
44
Citations
1019
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Del Fante C, Mortellaro C, Recupero S, Giorgiani G, Agostini A, Panigari A, et al.
Diagnostics (Basel)
. 2023 Jul;
13(13).
PMID: 37443651
Despite the substantial transfusion requirements, there are few studies on the optimal transfusion strategy in pediatric patients undergoing hematopoietic stem cell transplantation (HSCT). Our study aimed to retrospectively analyze red...
2.
Terenziani M, Tozzi A, Diaco L, Biasin E, Cattoni A, Croci I, et al.
Tumori
. 2023 Jul;
109(6):555-561.
PMID: 37434559
Introduction: Quality of life in childhood cancer survivors is largely affected by survivorship care and transition from treatment to long-term follow-up (LTFU). Referring to evidence-based recommendations, we wanted to evaluate...
3.
Basso S, Compagno F, Zelini P, Giorgiani G, Boghen S, Bergami E, et al.
Front Immunol
. 2020 Nov;
11:567531.
PMID: 33178192
Dramatic progress in the outcome of allogeneic hematopoietic stem cell transplantation (allo-HSCT) from alternative sources in pediatric patients has been registered over the past decade, providing a chance to cure...
4.
Saglio F, Zecca M, Pagliara D, Giorgiani G, Balduzzi A, Calore E, et al.
Bone Marrow Transplant
. 2020 Jan;
55(10):1918-1927.
PMID: 31996791
Patients given allogeneic hematopoietic stem cell transplantation (alloHSCT) present an increased incidence of long-term toxicities that can be attributed to the preparative regimen. We retrospectively analyzed in a population of...
5.
Faraci M, Diesch T, Labopin M, Dalissier A, Lankester A, Gennery A, et al.
Biol Blood Marrow Transplant
. 2019 May;
25(9):1786-1791.
PMID: 31082473
Gonadal impairment is an important late effect with a significant impact on quality of life of transplanted patients. The aim of this study was to compare gonadal function after busulfan...
6.
Beneventi F, Locatelli E, Simonetta M, Cavagnoli C, Pampuri R, Bellingeri C, et al.
Bone Marrow Transplant
. 2018 Mar;
53(9):1157-1164.
PMID: 29545593
To study vaginal development and sexual functioning in young women after childhood hemopoietic stem cell transplantation (HSCT) and radio/chemotherapy. Observational case-control study on 30 young sexually active women survived after...
7.
Locatelli F, Bernardo M, Bertaina A, Rognoni C, Comoli P, Rovelli A, et al.
Lancet Oncol
. 2017 Jul;
18(8):1126-1136.
PMID: 28705454
Background: Although rabbit anti-T-lymphocyte globulin (ATLG) is largely used for the prevention of immune-mediated complications in patients given allogeneic haemopoietic stem-cell transplantation (HSCT) from an unrelated donor, the optimum dose...
8.
Strocchio L, Zecca M, Comoli P, Mina T, Giorgiani G, Giraldi E, et al.
Br J Haematol
. 2015 Mar;
169(5):726-36.
PMID: 25818248
Although allogeneic haematopoietic stem cell transplantation (HSCT) still represents the only consolidated possibility of cure for sickle cell disease (SCD) patients, its use has been limited by the risk of...
9.
Beneventi F, Locatelli E, Giorgiani G, Zecca M, Mina T, Simonetta M, et al.
Fertil Steril
. 2014 Dec;
103(2):455-61.
PMID: 25497446
Objective: To compare uterine and ovarian volumes and uterine artery (UA) Doppler blood flow among women who were treated with antineoplastic regimens when pediatric aged versus healthy controls. Design: Case-control...
10.
Algeri M, Comoli P, Strocchio L, Perotti C, Corbella F, Del Fante C, et al.
J Pediatr Hematol Oncol
. 2014 Nov;
37(4):322-6.
PMID: 25374286
Allogeneic hematopoietic stem cell transplantation (HSCT) is the only cure for marrow failure associated with dyskeratosis congenita (DC). Data on transplants from alternative donors are limited. We describe a boy...